RxE2

📍 Fargo, United States🗓 Founded 2020👥 19 employees💰 Last funded Oct 2019

Committed to improving the way clinical trials are managed, making them more efficient and effective to drive more drugs to the market faster, RXE2 is focused on leveraging the power of community, and specifically community pharmacists, providing them with powerful and cutting-edge technology, so that they can help the pharmaceuticals with their challenges in clinical trials. Clinical studies traditionally take many years and cost hundreds of millions of dollars to design, run and analyze. The biggest challenges pharmaceutical companies face when it comes to clinical trials and research are usually patient recruitment (both in time and diversity), patient engagement and retention (patient adherence to the protocol, dropout rates) and the logistics of drug dispensing and counseling. RXE2 taps into its vast network of community pharmacists and leverages their expertise, knowledge of their communities and patients and the trust they enjoy by their patients to help the pharmaceuticals resolve these challenges. We do all this with powerful AI, Machine Learning and other cutting-edge technologies.

Total investors

Early stage

Mid stage

Late stage

2020

Founded